← Back to Search

Dual X-ray Absorptiometry for Prostate Cancer

N/A
Waitlist Available
Led By Brian Focht, PhD, FACSM
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 week
Awards & highlights

Study Summary

This trial looks at quality of life for people who have had radiation therapy for prostate cancer, to see how treatment affects patients.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Develop an understanding of the impacts of prostate cancer on HRQL measured by the SF-36
Explore whether heart rate variability is associated with the SF-36 and Connor Davidson Resiliency Scale.
Psychological resiliency measured by Connor Davidson Resiliency Scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (quality of life, supportive care preferences)Experimental Treatment5 Interventions
Participants complete questionnaires about quality of life and preferences for supportive care treatment, wear accelerometerundergo heart rate variability(HRV) testing over 10-15 minutes while both lying down and standing, complete a walking test, wear an accelerometer for a period of 1 week, and undergo a single Dual X-ray Absorptiometry (iDXA) scan over 10 minutes. Other interventions include: Laboratory Biomarker Analysis, Quality-of-Life Assessments, and othe Questionnaire Administration.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dual X-ray Absorptiometry
2015
N/A
~50

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,201 Total Patients Enrolled
9 Trials studying Prostate Cancer
2,164 Patients Enrolled for Prostate Cancer
Brian Focht, PhD, FACSMPrincipal InvestigatorOhio State University Comprehensive Cancer Center
1 Previous Clinical Trials
16 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical experiment actively seeking volunteers?

"The details on clinicaltrials.gov demonstrate that this study is not currently recruiting patients, despite first being posted in May 2016 and last updated June 3rd 2022. Despite the lack of recruitment for this particular trial, 1322 other medical studies are actively seeking out participants at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors
Brian Focht 2016. "Quality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02704377.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top